ECA
PETS icon

Elevated Capital Advisors’s PetMed Express PETS Stock Holding History

Elevated Capital Advisors’s Portfolio PETS Stock Details PETS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$96 Hold
50
– – ﹤0.01% 841
2026
Q1 		$114 Hold
50
– – ﹤0.01% 834
2025
Q4 		$160 Buy
+50
New +$125 ﹤0.01% 815

Other funds holding PETS

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SPH
Steel Partners Holdings New York $78M AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
RC
Rangeley Capital New Canaan, Connecticut $109M AUM 97.13% 1-Year Est. Return

Elevated Capital Advisors's PETS Position: Q2 2026 in Review

Elevated Capital Advisors held its PetMed Express (PETS) position steady in Q2 2026 at 50 shares worth $96. The position accounts for ﹤0.01% of the portfolio, ranked #841.

Elevated Capital Advisors first reported a position in PETS in Q4 2025 and has held it in 3 quarters since. The position peaked at $160 in Q4 2025. 50 funds tracked by Wall St. Rank hold PETS as of Q2 2026.

  • Elevated Capital Advisors held 50 shares of PetMed Express worth $96 as of Q2 2026.
  • Elevated Capital Advisors left its PetMed Express share count unchanged in Q2 2026.
  • PetMed Express made up ﹤0.01% of Elevated Capital Advisors's portfolio in Q2 2026, its #841 holding.
  • Elevated Capital Advisors first reported a position in PetMed Express in Q4 2025 and has held it in 3 quarters since.
  • Elevated Capital Advisors's PetMed Express position peaked at $160 in Q4 2025.
  • 50 funds tracked by Wall St. Rank held PetMed Express as of Q2 2026.

Based on Elevated Capital Advisors's 13F filing for Q2 2026, filed 3 Aug 2026.